VACCINES IN YOUR POCKET

DR. SAUMYA SWAMINATHAN Cheif Scientist, World Health Organisation

DIABETES, AT CLOSE TO 91 MILLION CASES, ACCOUNTS FOR 25% OF ALL NCDS IN INDIA

The disease incidence, which increases very rapidly in individuals above 35 years of age, accounts for 12.8 million DALYs, 6.7 million YLDs

EXPERTS PREDICT THIRD WAVE IN INDIA WITH MORE THAN A LAKH DAILY CASES IN FEBRUARY

The active cases have come down as compared July leveld, the threat of new variants is looming large.

END INEQUALITIES TO MEET THE TARGET OF ENDING AIDS

Forty years after the first AIDS case was reported, and 35 years since the first case in India, HIV still threatens us. Today, the world is off track from delivering on the shared commitment to end AIDS by 2030.

UK approves sotrovimab as new covid treatment for high risk adults

The Medicines and Healthcare Products Regulatory Agency (MHRA), the drug regulator of the UK, has approved sotrovimab, branded as Xevudy, a new biological drug to fight Covid-19. The drug was found effective to reduce the likelihood of hospital admission and death by about 79 percent in high-risk adults.

Critical Use Of Tractography In Removal Of Brain Tumours

Among Indian surgeons, it is rare to find the skilful art of using Diffusion Tensor Imaging-Fiber Tractography (DTI-FT), a novel MRI technique, to locate the facial nerve on the surface of the brain tumour before surgery

DIGITAL THERAPEUTICS: CHANGING PARADIGMS IN DIABETES CARE

With the emergence of DTx programs, doctors and healthcare staffcan extend their care and monitor a patient remotely for faster recovery

ROLE OF NUTRACEUTICALS IN MODERN HEALTHCARE

With the pandemic teaching us the importance of overall nutrition, people are getting more flexible toward nutraceuticals

Liposomal Nanotechnology and its role in vaccine delivery systems

In the recent past, there have been many projects to develop sub-unit vaccines that are more effective and defined

CIDRAP RELEASES INFLUENZA VACCINES R&D ROADMAP TO IMPROVE FLU VACCINES

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, has released an Influenza Vaccines Research and Development Roadmap (IVR) to accelerate the development of improved seasonal influenza vaccines and the generation of broadly protective or universal influenza vaccines that could mitigate the impact of future influenza pandemics.

“CONNECTING THE PATIENT ON VIDEO WITH A DOCTOR IS NOT DIGITAL HEALTH, THERE IS MUCH MORE TO IT”

Digital health is the way forward for the world at a time when it is going through one of its most uncertain phases during which mobility has been affected, the economy is in peril and human health is in danger. In June, New York Stock Exchange saw the listing of a company that can truly impact the future of world healthcare in this context. UpHealth Holdings, Inc., which was born through a reverse merger of four companies, combines the four essential components of digital healthcare — a low cost, but accountable system of care, an integrated care management platform, a tech-enabled behavioral health service unit and a full-service e-pharmacy capability. The new entity, which began trading on the NYSE at $9.29 a share on June 10th, was formed by the merger of Glocal Healthcare, a social venture and one of India’s pioneer digital health companies, and three US-based entities Thrasys, BHS & Transformations, and MedQuest. The company focuses on the three As of future healthcare — access anywhere, affordability for everyone and accountability of health outcomes. The founder of Glocal Healthcare and the chief architect of this new global healthcare fusion, DR SYED SABAHAT AZIM — a physician and former Indian Administrative Service (IAS) official, envisioned this a long time ago when he founded Glocal in 2010. Glocal was conceived as a social enterprise bringing quality healthcare to rural India through a combination of low cost primary and secondary care hospitals and digital dispensaries powered by technology. However, says he, the majority of the world, including people engaged in the service of healthcare, is yet to fully understand ‘digital health’ and ‘telemedicine’. Dr Sabahat says the term digital health is often misinterpreted even by healthcare providers, in an exclusive interview with Editor CH UNNIKRISHNAN.

Covid-19: India To Vaccinate All Above 18

The central government has started vaccination for everyone above the age of 18 from May 1, 2021.

Viloxazine for treatment of ADHD

Supernus Pharmaceuticals announced that the US FDA approved viloxazine extended-release capsules (Qelbree) for the treatment of attention-deficit hyperactivity disorder (ADHD) in paediatric patients 6 to 17 years of age.

SECNIDAZOLE SHOWS HIGHER CURE RATES IN TRICHOMONIASIS

The use of antibiotic secnidazole was found to be effective in treating women with trichomoniasis, according to a recent phase 3 study now published in the journal Clinical Infectious Diseases.

DOCS RUE VIP CULTURE IN GOVT HOSPITALS

Politicians and bureaucrats without severe illness demand preferential treatment, causing great hardship to the overstrained frontline, say doctors

CONVALESCENT PLASMA TREATMENT GUIDELINES

Plasma from donors who have recovered from COVID-19 may contain antibodies to SARS-CoV-2 that may help suppress the virus and modify the inflammatory response.1 The Food and Drug Administration (FDA) issued an Emergency Use Authorisation (EUA) for convalescent plasma for the treatment of certain hospitalised patients with COVID-19.

SHOULD A DOCTOR PAY FOR MRs?

Paid consultation from the pharma field force could run into several challenges

ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES TREATMENT GUIDELINES

The SARS-CoV-2 genome encodes four major structural proteins: spike (S), envelope (E), membrane (M), and nucleocapsid (N), as well as nonstructural and accessory proteins. The S protein is further divided into two subunits, S1 and S2, that mediate host cell attachment and invasion. Through its receptor-binding domain (RBD), S1 attaches to angiotensin-converting enzyme 2 (ACE2) on the host cell; this initiates a conformational change in S2 resulting in virus-host cell membrane fusion and viral entry.

VACCINATION CONSIDERATIONS FOR PEOPLE WHO ARE PREGNANT OR BREASTFEEDING

CDC and the independent Advisory Committee on Immunization Practices (ACIP) have provided information to assist pregnant people with their decision to receive the COVID-19 vaccine.

PAMDA AWARDS 2021 - HOLISTIC HEALER

Dr BELLE MONAPPA HEGDE Recipient of Padma Vibhushan, 2021

People have option to receive or reject Covaxin: Bharat Bio

Individuals offered to receive Covaxin will have the option to receive or reject administration of the vaccine, according to a fact sheet issued by Bharat Biotech.

CHRONICLING COVID-19

Covid-19: What You Need to Know About the Coronavirus and the Race for the Vaccine by Dr Michael Mosley is one of the most comprehensive compilations on COVID-19 and SARS-CoV-2, the virus behind the pandemic.

Hijacking Coagulation Using Platelets

One-third of COVID-19 patients in ICUs develop thrombotic complications leading to high morbidity

SHIGELLA SCARE IN KERALA

The southern Indian state is on high alert following an outbreak of shigellosis

VACCINE SAFETY IS ALWAYS A MATTER OF RISKS AND BENEFITS, BUT TECH ADVANCES HELP REDUCE THE RISK: EXPERTS

The FM December webinar delved into concerns around the safety and efficacy of rapidly-developed COVID-19 vaccines authorised for emergency use

A World Without Aids: Still A Distant Dream

Nearly four decades later, HIV continues to elude a cure and defies all efforts to wipe it out

FOOD ADDITIVES TRIGGERING COELIAC?

Studies suggest certain food additives could be behind the rising incidence of the gut-damaging autoimmune disease

MANAGEMENT OF CO-INFECTION OF COVID-19 WITH OTHER SEASONAL EPIDEMIC PRONE DISEASES

Almost all States/UTs of the country are affected by COVID-19. Given the seasonal pattern of epidemic-prone diseases observed every year in our country, it diseases like Dengue, Malaria, Seasonal Influenza, Leptospirosis, Chikungunya, Enteric fever, etc. can not only present as a diagnostic dilemma but may co-exist in COVID cases.

CENTRE MOVES TO INTEGRATE ALLOPATHY WITH AYUSH: IMA SEES RED

CCIM decision to allow ayur doctors practice surgery draws flak

“Any definitive conclusion on SArS-CoV-2 immunity needs more evidence”

Dr Chandrakant Lahariya is a medical doctor and a leading public policy and health systems expert.